NO REDUCTION IN BLEEDING ASSOCIATED WITH BIVALIRUDIN USE WHEN COMPARED TO UNFRACTIONATED HEPARIN AMONG PATIENTS WITH STABLE ISCHEMIC HEART DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

被引：0
|
作者：
Kellogg, Morgan
Huang, Yi-Ling
MacKenzie, Todd A.
Ahmed, Bina
Watkins, Matthew
Magnus, Patrick
Flynn, Jim
Lee, Peter N. Ver
Malenka, David
Vasaiwala, Samip C.
机构：
[1] Maine Med Ctr, Northern New England Cardiovasc Dis Study Grp, Portland, ME 04102 USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)30758-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A217
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [41] Bivalirudin Versus Unfractionated Heparin in Percutaneous Coronary Intervention for Stable Angina: A Randomized Clinical Trial (STATUS-PCI)
    Lima, Fabio
    Gruberg, Luis
    Aslam, Usman
    Clase, Kydanis
    Ramgadoo, Melissa
    Trevisan, Alessandra
    Jeremias, Allen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [42] Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States
    Secemsky, Eric A.
    Kirtane, Ajay
    Bangalore, Sripal
    Jovin, Ion S.
    Shah, Rachit M.
    Ferro, Enrico G.
    Wimmer, Neil J.
    Roe, Matthew
    Dai, Dadi
    Mauri, Laura
    Yeh, Robert W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (23) : 2376 - 2386
  • [43] Percutaneous coronary intervention for the management of stable ischemic heart disease
    Liu, Shuangbo
    Tsang, Michael
    Abdel-Qadir, Husam
    Yanagawa, Bobby
    Bagai, Akshay
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (05) : 557 - 563
  • [44] Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes
    Farag, Mohamed
    Gorog, Diana A.
    Prasad, Abhiram
    Srinivasan, Manivannan
    OPEN HEART, 2015, 2 (01):
  • [45] Long-term mortality in asymptomatic patients with stable ischemic heart disease undergoing percutaneous coronary intervention
    Koshy, Anoop N.
    Dinh, Diem T.
    Fulcher, Jordan
    Brennan, Angela L.
    Murphy, Alexandra C.
    Duffy, Stephen J.
    Reid, Christopher M.
    Ajani, Andrew E.
    Freeman, Melanie
    Hiew, Chin
    Oqueli, Ernesto
    Farouque, Omar
    Yudi, Matias B.
    Clark, David J.
    AMERICAN HEART JOURNAL, 2022, 244 : 77 - 85
  • [46] Bivalirudin Vs Unfractionated Heparin during Percutaneous Coronary Intervention in High Risk Patients for Bleeding. AntiCoagulant Regimen In high risk PAtients for Bleeding - ACRIPAB Trial
    Feldman, A.
    Suleiman, K.
    Bushari, L.
    Rozner, E.
    Freedberg, N. A.
    Turgeman, Y.
    EUROPEAN HEART JOURNAL, 2012, 33 : 842 - 842
  • [47] Routine Use of Bivalirudin Reduces Bleeding and Increases Ischemic Complications During Percutaneous Coronary Intervention
    Yarkoni, Alon
    Kini, Annapoorna S.
    Krishnan, Prakash
    Kim, Michael C.
    Moreno, Pedro R.
    Kodali, Visali
    Sharma, Samin S.
    CIRCULATION, 2009, 120 (18) : S934 - S935
  • [48] Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention A meta-analysis of randomized controlled trials
    Liu, Xiao-Qiang
    Luo, Xian-Du
    Wu, Yan-Qing
    MEDICINE, 2020, 99 (06)
  • [49] Adjunctive therapy during percutaneous coronary intervention with bivalirudin reduces myeloperoxidase (MPO) levels as compared with eptifibatide plus unfractionated heparin
    Berlin, HA
    Fierschnaller, VL
    Hall, MJ
    Smyth, SS
    Steinhubl, SR
    Keenan, AC
    Young, JC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E66 - E66
  • [50] One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention
    Li, Yulong
    Li, Jiawen
    Guan, Changdong
    Su, Shuhong
    Wang, Zhifang
    Liu, Haiwei
    Yang, Yuejin
    Gao, Runlin
    Yuan, Jinqing
    Zhao, Xueyan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (10)
12345